ASSET PURCHASE AGREEMENT BY AND BETWEEN SORRENTO THERAPEUTICS, INC., AND YUHAN CORPORATION DATED AS OF OCTOBER 30, 2023Asset Purchase Agreement • November 3rd, 2023 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 3rd, 2023 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 30, 2023 by and between SORRENTO THERAPEUTICS, INC., a Delaware corporation (“Seller”), and YUHAN CORPORATION, a Korean corporation (“Buyer”). Seller and Buyer are referred to herein each as a “Party” and together as the “Parties.” Capitalized terms used but not otherwise defined herein have the meanings set forth in Article I.
MANUFACTURING TECHNOLOGY TRANSFER AGREEMENTManufacturing Technology Transfer Agreement • November 3rd, 2023 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 3rd, 2023 Company Industry JurisdictionThis MANUFACTURING TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”) is made and entered into as of November 2, 2023 (the “Effective Date”) by and among SORRENTO THERAPEUTICS, INC., a Delaware corporation (“Seller”) and YUHAN CORPORATION, a Korean corporation (“Buyer”). Each of Seller and Buyer are referred to herein as a “Party” and together as the “Parties.”